Evidence map›Paper›PMID 30272025›Full record

ArticleCommunications biology2018

Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells.

Sanna Vattulainen-Collanus, Mark Southwood, Xu Dong Yang, Stephen Moore, Prajakta Ghatpande, Nicholas W Morrell, Giorgio Lagna, Akiko Hata

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Genetic Delivery and Gene Therapy in Pulmonary Hypertension.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis-ten years later.American journal of physiology. Lung cellular and molecular physiology · 2020
    Review
  16. The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sanna Vattulainen-CollanusCardiovascular Research Institute, University of California, San Francisco, San Francisco, 94143, CA, USA.
Mark SouthwoodDepartment of Pathology, Papworth Hospital, Papworth Everad, Cambridge, CB23 3RE, UK.
Xu Dong YangDepartment of Medicine, University of Cambridge, Addenbrook's Hospital, Cambridge, CB2 0QQ, UK.
Stephen MooreDepartment of Medicine, University of Cambridge, Addenbrook's Hospital, Cambridge, CB2 0QQ, UK.
Prajakta GhatpandeCardiovascular Research Institute, University of California, San Francisco, San Francisco, 94143, CA, USA.
Nicholas W MorrellDepartment of Medicine, University of Cambridge, Addenbrook's Hospital, Cambridge, CB2 0QQ, UK.ORCID http://orcid.org/0000-0001-5700-9792
Giorgio LagnaCardiovascular Research Institute, University of California, San Francisco, San Francisco, 94143, CA, USA.
Akiko HataCardiovascular Research Institute, University of California, San Francisco, San Francisco, 94143, CA, USA. akiko.hata@ucsf.edu.ORCID http://orcid.org/0000-0003-3784-1738
University of California, San Francisco · USUniversity of Cambridge · GBPapworth Hospital · GB

Funding

Identification of a novel modulator of Pulmonary Artery HypertensionR01HL132058 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HATA, AKIKO · 2016 to 2019
$2.5M
TRNA Q BASE METABOLISM IN NORMAL AND TUMOR CELLSR01CA020919 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KATZE, JON R · 1985 to 1985
–
British Heart Foundation RG/13/4/30107Medical Research Council MR/K020919/1NHLBI NIH HHS R01 HL132058
6 · The paper itself

Abstract

The integrity of blood vessels is fundamental to vascular homeostasis. Inactivating mutations in the bone morphogenetic protein (BMP) receptor type II (BMPR2) gene cause hereditary vascular disorders, including pulmonary arterial hypertension and hereditary hemorrhagic telangiectasia, suggesting that BMPR2 and its downstream signaling pathway are pivotal to the maintenance of vascular integrity through an unknown molecular mechanism. Here we report that inactivation of BMPR2 in pulmonary vascular endothelial cells results in a deficit of RAD51, an enzyme essential for DNA repair and replication. Loss of RAD51, which causes DNA damage and cell death, is also detected in animal models and human patients with pulmonary arterial hypertension. Restoration of BMPR2 or activation of the BMP signaling pathway rescues RAD51 and prevents DNA damage. This is an unexpected role of BMP signaling in preventing the accumulation of DNA damage and the concomitant loss of endothelial integrity and vascular remodeling associated with vascular disorders.

Identifiers

PMID30272025
PMCPMC6155317
OpenAlexW2891018881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.